Last updated: 17 July 2024 at 5:06pm EST

Joseph Wender Net Worth




The estimated Net Worth of Joseph H Wender is at least $7.61 Millón dollars as of 15 July 2024. Mr. Wender owns over 4,677 units of Ionis Pharmaceuticals Inc stock worth over $5,646,113 and over the last 10 years he sold IONS stock worth over $796,300. In addition, he makes $1,163,120 as Independent Director at Ionis Pharmaceuticals Inc.

Mr. Wender IONS stock SEC Form 4 insiders trading

Joseph has made over 25 trades of the Ionis Pharmaceuticals Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 4,677 units of IONS stock worth $198,913 on 15 July 2024.

The largest trade he's ever made was exercising 30,000 units of Ionis Pharmaceuticals Inc stock on 17 July 2018 worth over $277,800. On average, Joseph trades about 5,561 units every 97 days since 2015. As of 15 July 2024 he still owns at least 132,756 units of Ionis Pharmaceuticals Inc stock.

You can see the complete history of Mr. Wender stock trades at the bottom of the page.





Joseph Wender biography

Joseph H. Wender serves as Independent Director of the Company. Mr. Wender began with Goldman, Sachs & Co. in 1971 and became a General Partner of that firm in 1982, where he headed the Financial Institutions Group for over a decade. Since January 2008, he has been a Senior Consultant to Goldman Sachs & Co. He is a former Independent Trustee of the Schwab Family of Funds and Director of Grandpoint Capital, a bank holding company. Mr. Wender also is co-CEO and partner of Colgin Cellars. Since March 2014, Mr. Wender has been a Director of Outfront Media, a lessor of advertising space on out-of-home advertising structures, and has served as its Lead Independent Director since 2016.

What is the salary of Joseph Wender?

As the Independent Director of Ionis Pharmaceuticals Inc, the total compensation of Joseph Wender at Ionis Pharmaceuticals Inc is $1,163,120. There are 10 executives at Ionis Pharmaceuticals Inc getting paid more, with Stanley Crooke having the highest compensation of $9,598,830.



How old is Joseph Wender?

Joseph Wender is 75, he's been the Independent Director of Ionis Pharmaceuticals Inc since 1994. There are 2 older and 24 younger executives at Ionis Pharmaceuticals Inc. The oldest executive at Ionis Pharmaceuticals Inc is Breaux Castleman, 79, who is the Independent Director.

What's Joseph Wender's mailing address?

Joseph's mailing address filed with the SEC is 2855 GAZELLE COURT, , CARLSBAD, CA, 92010.

Insiders trading at Ionis Pharmaceuticals Inc

Over the last 9 years, insiders at Ionis Pharmaceuticals Inc have traded over $32,069,332 worth of Ionis Pharmaceuticals Inc stock. The most active insiders traders include Stanley T Crooke, B Lynne Parshall y Michael R Hayden. On average, Ionis Pharmaceuticals Inc executives and independent directors trade stock every 8 days with the average trade being worth of $445,289. The most recent stock trade was executed by Richard S Geary on 28 August 2024, trading 651 units of IONS stock currently worth $32,159.



What does Ionis Pharmaceuticals Inc do?

ionis pharmaceuticals, inc., located in the north san diego county city of carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. we are the pioneer in the discovery and development of antisense drugs with more than 1300 patents. ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. we are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. join us and experience our unique culture while you develop and expand your career. for more information about ionis and to apply for an open position, please visit our website: www.ionispharma.com.



Complete history of Mr. Wender stock trades at Ionis Pharmaceuticals Inc y Outfront Media Inc

Persona
Trans.
Transacción
Precio total
Joseph H Wender
Director
Uso de opción $222,485
15 Jul 2024
Joseph H Wender
Director
Uso de opción $568,480
9 May 2024
Joseph H Wender
Director
Uso de opción $300,042
17 Jul 2023
Joseph H Wender
Director
Uso de opción $314,401
15 Jul 2022
Joseph H Wender
Director
Uso de opción $309,116
15 Jul 2021
Joseph H Wender
Director
Uso de opción $465,975
16 Sep 2020
Joseph H Wender
Director
Uso de opción $240,800
1 Jul 2020
Joseph H Wender
Director
Uso de opción $187,207
1 Jul 2019
Joseph H Wender
Director
Venta $796,300
19 Mar 2019
Joseph H Wender
Director
Uso de opción $277,800
17 Jul 2018
Joseph H Wender
Director
Uso de opción $111,134
1 Jul 2018
Joseph H Wender
Director
Uso de opción $208,200
11 May 2018
Joseph H Wender
Director
Uso de opción $125,598
1 Jul 2017
Joseph H Wender
Director
Uso de opción $51,648
1 Jul 2016
Joseph H Wender
Director
Uso de opción $51,648
1 Jul 2016
Joseph H Wender
Director
Uso de opción $140,252
6 Jun 2024
Joseph H Wender
Director
Uso de opción $107,163
6 Jun 2023
Joseph H Wender
Director
Uso de opción $97,600
7 Jun 2022
Joseph H Wender
Director
Uso de opción $155,649
8 Jun 2021
Joseph H Wender
Director
Uso de opción $86,899
8 Jun 2020
Joseph H Wender
Director
Uso de opción $156,649
10 Jun 2019
Joseph H Wender
Director
Uso de opción $106,193
12 Jun 2018
Joseph H Wender
Director
Uso de opción $115,892
7 Jun 2017
Joseph H Wender
Director
Uso de opción $102,915
9 Jun 2016
Joseph H Wender
Director
Uso de opción $73,359
28 Mar 2015


Ionis Pharmaceuticals Inc executives and stock owners

Ionis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: